AMRX

Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Holding Co

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:AMRX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	05:05	Business Wire	Amneal to Participate at Upcoming Investor Conference	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/23	05:05	Business Wire	Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/17	04:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/17	04:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/15	05:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/15	05:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/15	05:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/15	05:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/08	05:18	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/07	06:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/07	06:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/07	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/07	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/07	06:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/03	19:14	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/05/03	19:00	Business Wire	Amneal Reports First Quarter 2024 Financial Results	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/04/24	21:00	Business Wire	Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/04/16	21:00	Business Wire	Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/04/10	21:00	Business Wire	Amneal to Report First Quarter 2024 Results on May 3, 2024	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/29	05:05	Business Wire	Amneal to Ring the Nasdaq Closing Bell on April 2, 2024	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/26	05:05	Business Wire	Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/22	21:01	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/22	21:01	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/07	07:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/07	07:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/06	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/06	06:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/01	20:13	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/01	20:00	Business Wire	Amneal Reports Fourth Quarter and Full Year 2023 Financial Results	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
2024/03/01	06:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co